5-fluoro-1- (2'-deoxy-2'-fluoro-β-D-ribofuranosyl) uracil trapping in morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene
Germann, C.; Shields, A.F.; Grierson, J.R.; Morr, I.; Haberkorn, U.
The Journal of Nuclear Medicine (1978) 39(8): 1418-1423
1998
ISSN/ISBN: 0161-5505 Accession: 075507790
PDF emailed within 1 workday: $29.90
Related References
Germann, C.; Shields, A.F.; Grierson, J.R.; Morr, I.; Haberkorn, U. 1998: 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 39(8): 1418-1423Nimmagadda, S.; Mangner, T.J.; Lawhorn-Crews, J.M.; Haberkorn, U.; Shields, A.F. 2009: Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil) European Journal of Nuclear Medicine and Molecular Imaging 36(12): 1987-1993
Wigdahl, B.L.; Parkhurst, J.R. 1978: Inhibition of mouse l fibroblast cell and herpes simplex virus replication by 5 tri fluoro methyl 2 deoxy uridine role of l cell and herpes simplex virus induced deoxy thymidine kinase Abstracts of the Annual Meeting of the American Society for Microbiology 78: 8
Balatoni, J.A.; Doubrovin, M.; Ageyeva, L.; Pillarsetty, N.; Finn, R.D.; Gelovani, J.G.; Blasberg, R.G. 2005: Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2'-fluoro-2'-deoxy-5-[18F]fluoroethyl-1-beta-d-arabinofuranosyl uracil Nuclear Medicine and Biology 32(8): 811-819
Soloman, J. 1980: Plasma concentrations of 5 fluoro uracil 5 fluorodeoxy uridine thymine and thymidine in man during 5 day infusion of 5 fluoro uracil and thymidine preceded by bolus 5 fluoro uracil and thymidine Proceedings of the American Association for Cancer Research and American Society of Clinical Oncology 21
Reeves, W.J.Jr; Cailleau, R.M. 1970: Relation between resistance to 5 fluoro uracil 5 fluoro deoxy uridine and thymidine in ehrlich ascites carcinoma cells in vitro In Vitro 6(3): 240
Chen, M.S.; Summers, W.P.; Walker, J.; Summers, W.C.; Prusoff, W.H. 1979: Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus Journal of Virology 30(3): 942-945
Wilkinson, D.S.; Crumley, J. 1976: Biochemical basis of 5 fluoro uracil resistance in thymidine kinase deficient novikoff hepatoma cells Federation Proceedings 35(7): 1110
Abrams, D.N.; Mercer, J.R.; Knaus, E.E.; Wiebe, L.I. 1985: The synthesis of radiolabelled 1-(2'-fluoro-2'-deoxy-β-D-ribofuranosyl)-uracil and 1-(2'-chloro-2'-deoxy-β-D-ribofuranosyl) uracil The International Journal of Applied Radiation and Isotopes 36(3): 233-238
Morin, K.W.; Duan, W.; Knaus, E.E.; McEwan, A.J.B.; Wiebe, L.I. 2005: A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine Nuclear Medicine and Biology 32(5): 459-464
Fwulai, L.I.N.; Sternberg, N. 1984: Homologous recombination between segments of the herpes simplex virus thymidine kinase gene in mouse L cells - Recombinaison homologue entre les segments du gène de la thymidine kinase du virus herpès simplex dans les cellules L de souris Progress in Cancer Research and Therapy 30: 47-51
Charron, J.; Langelier, Y. 1981: Analysis of deoxy cytidine deaminase activity in herpes simplex virus infected or herpes simplex virus thymidine kinase transformed cells association with mycoplasma contamination not with virus infection Journal of General Virology 57(1): 245-250
Haberkorn, U.; Altmann, A.; Morr, I.; Germann, C.; Oberdorfer, F.; van Kaick, G. 1997: Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 38(7): 1048-1054
Haberkorn, U.; Altmann, A.; Morr, I.; Germann, C.; Oberdorfer, F.; Van Kaick, G. 1997: Multitracer studies During gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir The Journal of Nuclear Medicine (1978) 38(7): 1048-1054
Strauss, M.; Kiessling, U.; Kähler, R. 1983: Plasmids expressing the Herpes simplex virus thymidine kinase gene in mammalian and bacterial cells Molecular and General Genetics: Mgg 191(1): 154-157
Haberkorn, U.; Altmann, A.; Morr, I.; Knopf, K.W.; Germann, C.; Haeckel, R.; Oberdorfer, F.; van Kaick, G. 1997: Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 38(2): 287-294
Haberkorn, U.; Altmann, A.; Morr, I.; Knopf, K.W.; Germann, C.; Haeckel, R.; Oberdorfer, F.; Van Kaick, G. 1997: Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells : Uptake of specific substrates The Journal of Nuclear Medicine (1978) 38(2): 287-294
Ido, A.; Nakata, K.; Kato, Y.; Nakao, K.; Muyrata, K.; Fujita, M.; Ishii, N.; Tamaoki, T.; Shiku, H.; Nagataki, S. 1995: Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter Cancer Research (Baltimore) 55(14): 3105-3109
Kanai, F.; Shiratori, Y.; Lan, K.H.; Kato, N.; Shiina, S.; Omata, M.; Yoshida, Y.; Wakimoto, H.; Hamada, H.; Kanegae, Y.; Saito, I.; Nakabayashi, H.; Tamaoki, T.; Tanaka, T. 1996: Gene therapy for α-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene Hepatology (Baltimore, Md.) 23(6): 1359-1368
Ido, A.; Nakata, K.; Kato, Y.; Nakao, K.; Murata, K.; Fujita, M.; Ishii, N.; Tamaoki, T.; Shiku, H.; Nagataki, S. 1995: Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter Cancer Research 55(14): 3105-3109